News

Advanced Micro Devices Earnings Anticipated; Analysts Adjust Predictions

Advanced Micro Devices Earnings Anticipated; Analysts Adjust Predictions

Analysts Update Predictions for AMD before Earnings Release

Advanced Micro Devices, Inc (NASDAQ: AMD) is gearing up to unveil its earnings results for the second quarter. This exciting event is anticipated to occur after the market closes, and investor attention is high as expectations for the results unfold.

Earnings Projections for AMD

Analysts predict that AMD will announce quarterly earnings of approximately 48 cents per share. This figure represents a significant decrease from the 69 cents per share reported during the same period last year. Nevertheless, the company is projected to report robust revenue figures of around $7.43 billion, marking an increase from $5.83 billion reported a year earlier. Such growth amidst earnings decline has sparked interest among investors and analysts alike.

Recent Developments Boosting Investor Confidence

In a recent development, AMD has licensed its FlexGen network-on-chip (NoC) interconnect technology for its upcoming generation of processors. This cutting-edge technology is designed to enhance data transport efficiency among AMD's chiplets, particularly for artificial intelligence applications deployed in data centers and various edge computing devices. These advancements are seen as crucial drivers for AMD's future growth and performance in the market.

Stock Performance Analysis

On the latest trading day before earnings, AMD shares experienced a boost of approximately 3%, closing at $176.78. Such momentum reflects the market's optimism surrounding the forthcoming earnings announcement and the company's innovative strides in technology. This increase also highlights the stock's resiliency amid fluctuating market conditions.

Analysts’ Ratings and Adjustments

Several analysts have adjusted their ratings and price targets for AMD in light of its expected performance:

  • Susquehanna analyst Christopher Rolland maintained a Positive rating and raised the price target from $135 to $210, showcasing a strong belief in AMD's potential.
  • Morgan Stanley's Joseph Moore held an Equal-Weight rating but increased the price target from $121 to $185, suggesting a positive outlook tailored to current market dynamics.
  • UBS analyst Timothy Arcuri upgraded AMD to a Buy rating, increasing the price target from $150 to $210, reflecting confidence in the company’s strategic direction and growth potential.
  • Bernstein's Stacy Rasgon maintained a Market Perform rating with a price target adjustment from $95 to $140, indicating a cautious yet hopeful stance.
  • Citigroup's Christopher Danely adjusted his Neutral rating and elevated the price target from $145 to $165, suggesting a moderate optimism awaiting the earnings outcomes.

Investor Considerations Before Making Decisions

Investors contemplating buying AMD stock should consider the insights provided by different analysts. Their updated perspectives could offer valuable guidance and shape decisions in relation to AMD's future growth trajectory. The overall sentiment from the market reflects a nuanced understanding of AMD's potential amidst the upcoming earnings announcement.

Frequently Asked Questions

What are AMD's expected earnings for this quarter?

Analysts project AMD to report earnings of approximately 48 cents per share.

How has AMD's stock performed recently?

AMD shares have seen a 3% increase, closing at $176.78 just before the earnings announcement.

What technological advancements is AMD focusing on?

AMD is set to implement its licensed FlexGen NoC technology to enhance the performance of its next-generation chips, targeting AI applications.

How are analysts rating AMD?

Analysts have given AMD mixed ratings, with significant price target adjustments reflecting optimism for growth.

What should investors consider before purchasing AMD stock?

Investors should evaluate the analysts' insights and the company's recent developments before making investment decisions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Zoomlion Unveils AI-Powered Gear at bauma CHINA 2026

Updated Category News Views 262

Setting the Stage for AI in Construction Now here's a scene that's hard to ignore—Zoomlion strutting its stuff at bauma CHINA 2026, putting over 60 examples of its AI-powered, new-energy technologies front and center. It's not every day we see a massive leap this big in the industry, and this November in Shanghai, Zoomlion's got plans to make sure we don't quickly...

Continue Reading
Paris Baguette Opens New Café in Novato, CA

Updated Category News Views 76

Another Feather in Paris Baguette’s Cap Alright, as far as pastry shops go, Paris Baguette is rolling out those cinnamon rolls like they're planting flags on the moon. They've just added a new café in Novato, California, bringing the artisanal charm of their iconic baked goods to yet another American doorstep. A Local Affair with Big Aspirations The man of the hour,...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 117

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 59

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Cemig and Huawei's Bold Network Leap: Power Up

Updated Category News Views 100

Taking the Leap in Brazil's Power Grid In Brazil, energy distribution's a whole different beast, and boy, is it complicated! Cemig found out the hard way that relying on public networks was a risky bet. Consistently bad. With a measly 50% coverage in Brazil's vast lands, you're looking at a communications nightmare, especially in the back of beyond where grid faults could...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 178

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 59

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Sportradar and DATA.BET: Expanding Esports Odds Offering

Updated Category News Views 109

A Shift in the Esports Betting Landscape Well, it looks like we’ve hit another significant milestone in the esports betting universe. Sportradar, the sports tech giant known for pushing boundaries, has forged an intriguing alliance with DATA.BET, a sportsbook hotshot hailing from Cyprus. We're talking about a deal that’s set to shake up the esports betting scene with...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Heart and Kidney Health Through Collaboration

Updated Category News Views 264

Collaboration for Health Awareness In an exciting development, the American Kidney Fund (AKF) has forged a partnership with the American Heart Association (AHA) as part of their Cardiovascular-Kidney-Metabolic Health Initiative™. This collaboration aims to raise awareness regarding the crucial link between kidney disease and cardiovascular conditions, both of which...

Continue Reading
Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown

Updated Category News Views 106

Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown Kering (EPA: PRTP) has recently experienced a shift in market sentiment as analysts express increasing caution regarding its performance. TD Cowen has notably lowered its price target for Kering to €230 from €260, while sustaining a Hold rating for the stock. The adjustment signals growing concerns...

Continue Reading
Xi Jinping Champions Common Development at G20 Summit

Updated Category News Views 308

Xi Jinping's Vision for Global Cooperation at the G20 Summit Chinese President Xi Jinping recently made headlines during a significant gathering known as the G20 Summit. His participation underscored a strong commitment to fostering global cooperation and development, marking a notable moment in international relations. Advocating for a Unified Approach During his...

Continue Reading
OHA Secures Financing for Onex's Acquisition of Farsound

Updated Category News Views 84

OHA Leads Innovative Financing for Strategic Acquisition In a significant development in the financial world, Oak Hill Advisors (OHA) has taken on the role of Lead Left Arranger for a private unitranche financing aimed at supporting the acquisition of Farsound Aviation Limited by Onex. Farsound stands out in the aerospace engine maintenance, repair, and overhaul (MRO)...

Continue Reading
Zentalis Pharmaceuticals Rebounds After FDA Clearance for Azenosertib

Updated Category News Views 75

Zentalis Pharmaceuticals Advances with Azenosertib Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), located in San Diego, has some exciting updates for its stakeholders. The U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the company's studies involving azenosertib. This is fantastic news, as it enables Zentalis to restart patient enrollment...

Continue Reading